Keros Therapeutics Inc. (KROS)
NASDAQ: KROS
· Real-Time Price · USD
13.63
0.07 (0.52%)
At close: Jun 16, 2025, 3:59 PM
13.65
0.11%
Pre-market: Jun 17, 2025, 08:24 AM EDT
Keros Therapeutics Revenue
Keros Therapeutics reported an annual revenue of $3.55M, reflecting a 2250.99% growth. For the quarter ending March 31, 2025, Keros Therapeutics generated $211.25M in revenue.
Revenue (ttm)
$3.55M
Revenue Growth
2250.99%
Price / Sales Ratio
166.94
Revenue / Employee
$21.78K
Employees
163
Market Cap
553.79M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | % Change |
|---|